Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
iRhythm Technologies, Inc. IRTC
$125.93
-$2.77 (-2.20%)
На 18:00, 12 мая 2023
+28.87%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
3923115500.00000000
-
week52high
164.69
-
week52low
85.74
-
Revenue
410921000
-
P/E TTM
-32
-
Beta
1.40726600
-
EPS
-3.96000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 20:00
Описание компании
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| BTIG | Buy | Buy | 05 авг 2022 г. |
| BTIG | Buy | Buy | 24 июн 2022 г. |
| JP Morgan | Overweight | Overweight | 22 июн 2022 г. |
| Truist Securities | Buy | Buy | 16 июн 2022 г. |
| Citigroup | Neutral | Buy | 09 июн 2022 г. |
| Canaccord Genuity | Buy | Buy | 02 сент 2022 г. |
| Morgan Stanley | Overweight | Overweight | 22 сент 2022 г. |
| JP Morgan | Overweight | Overweight | 22 сент 2022 г. |
| Truist Securities | Buy | Buy | 17 окт 2022 г. |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Needham | Buy | Buy | 02 ноя 2022 г. |
| Citigroup | Neutral | Neutral | 02 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
| Truist Securities | Buy | Buy | 20 дек 2022 г. |
| Citigroup | Neutral | Neutral | 12 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Murphy Patrick Michael | D | 23726 | 1704 | 02 дек 2022 г. |
| Wilson Daniel G. | D | 33562 | 1000 | 01 дек 2022 г. |
| Blackford Quentin S. | D | 89280 | 12415 | 02 ноя 2022 г. |
| Blackford Quentin S. | D | 101695 | 284 | 02 ноя 2022 г. |
| Devine Douglas | D | 27702 | 2000 | 29 сент 2022 г. |
| Wilson Daniel G. | D | 34562 | 500 | 26 сент 2022 г. |
| Wilson Daniel G. | D | 35062 | 435 | 26 сент 2022 г. |
| Wilson Daniel G. | D | 35497 | 1169 | 26 сент 2022 г. |
| Wilson Daniel G. | D | 36666 | 896 | 26 сент 2022 г. |
| Bairey Merz Cathleen Noel | D | 4887 | 90 | 12 сент 2022 г. |
Новостная лента
The 3 Best MedTech Stocks to Watch in May 2023
InvestorPlace
11 мая 2023 г. в 06:09
Finding the best MedTech stocks to watch in May can be a challenge. After all, the category is huge.
iRhythm Technologies, Inc. (IRTC) Q1 2023 Earnings Call Transcript
Seeking Alpha
07 мая 2023 г. в 10:02
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President & Chief Executive Officer Brice Bobzien - Chief Financial Officer Dan Wilson - EVP of Corporate Development and Investor Relations Conference Call Participants Allen Gong - JPMorgan Marie Thibault - BTIG Nathan Treybeck - Wells Fargo Cecilia Furlong - Morgan Stanley Richard Newitter - Truist Securities Bill Plovanic - Canaccord Suraj Kalia - Oppenheimer Operator Welcome to the iRhythm Technologies, Inc. Q1 2023 Earnings Conference Call. My name is Lauren, and I will be coordinating your call today.
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
04 мая 2023 г. в 19:44
IRhythm Technologies (IRTC) came out with a quarterly loss of $1.29 per share versus the Zacks Consensus Estimate of a loss of $0.80. This compares to loss of $0.80 per share a year ago.
iRhythm Technologies to Report First Quarter 2023 Financial Results on May 4, 2023
GlobeNewsWire
20 апр 2023 г. в 16:05
SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2023 after the close of trading on Thursday, May 4, 2023. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT/4:30 p.m. ET.
The 7 Most Innovative Stocks to Invest in Today
InvestorPlace
18 апр 2023 г. в 16:00
2022 was a forgettable year for financial markets. That also included several of the most popular innovative stocks.